Compass Pathways Plc (NASDAQ: CMPS)
Compass Pathways Plc Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Compass Pathways Plc Company Info
Compass Pathways Plc is an investment holding company. It operates through its subsidiaries which provide mental health care services. The company was founded by Goldsmith George Jay and Malievaskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.
News & Analysis
Compass Pathways' Losses Widen in Q3
With its clinical trials at a pivotal stage, Compass Pathways is burning more cash, but reported a slightly narrower-than-expected net loss.
Compass Pathways' Costs Rise in Q2 as Clinical Trials Advance
The pre-revenue biotech made clinical progress and enhanced its leadership team.
Should You Buy the Dip on Compass Pathways Stock?
Nothing is going wrong, but one of its peers just hit a serious snag.
These 2 Catalysts Could Soon Send Compass Pathways Stock Soaring
Psychedelic medicines are rapidly gaining legitimacy on several fronts.
Wall Street Says Compass Pathways Could Rise 307%. Here's How It Could Actually Happen.
The lofty target is closer to being within reach than it may seem at first.
3 Big New Catalysts for Psychedelics Stocks in 2024
This could be the year that psychedelics stocks start to fly.
This Unexpected Development Is Yet Another Green Flag for Compass Pathways Stock
For biotechs developing psychedelic therapies, good news comes in many forms.
Can Compass Pathways' Stock Gain 458% Like Wall Street Is Expecting?
Wall Street might have the timing wrong, but their hopes aren't misplaced.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.